High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer (Q36070061)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer |
scientific article |
Statements
1 reference
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer (English)
1 reference
M P H M Jansen
1 reference
E A Reijm
1 reference
A M Sieuwerts
1 reference
K Ruigrok-Ritstier
1 reference
M P Look
1 reference
F G RodrĂguez-González
1 reference
A A J Heine
1 reference
J W Martens
1 reference
S Sleijfer
1 reference
J A Foekens
1 reference
E M J J Berns
1 reference
18 November 2011
1 reference
1 reference
937-947
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference